MGF

MGF is a splice variant of IGF-1 produced in muscle tissue that activates satellite cells to promote hypertrophy and repair; off-label, people run it for muscle growth and recovery, though the entire captured community corpus is only five reports and outcomes are split. Community posts rarely specify dosing, while clinician sources cite 200 mcg by intramuscular injection, though timing and cycling remain largely unspecified. It carries no FDA-approved indication for human use, so all human use is off-label or compounded.

MGF

Research Evidence

Evidence shape

MGF sits at the animal-only tier: exactly one indication is mapped, entirely to preclinical mechanistic research, and zero trials are registered. No trials have been completed, leaving no posted results to evaluate. Beyond that single animal-only area, the dataset holds no thin indications and no populated clinical programs; the total absence of clinical data is the signal.

Depthhow much
0 registered trials
Breadthhow many areas
1 indication mapped
1 animal-only
Qualityhow rigorous
No completed trials
Breadth and depth24 rows captured
Human
direct clinical signal
0
Animal
translational support
12
In vitro
mechanistic support
12
HighMediumLow

Anecdotal efficacy

Side effects

Clinical research side effects

Clinical safety table not projected yet.

Anecdotal side effects

Price

1
US
1500 mg
$20.00
$0.01/mg
2
HK
20 mg
$40.00
$2/mg
3
JP
2 mg
$16.54
$8.27/mg
4
US
5 mg
$44.00
$8.8/mg
5
UK
2 mg
$18.79
$9.39/mg
6
US
2 mg
$19.75
$9.88/mg

price offers can be sorted by column

1-6 of 23

Dosing & Protocol

How MGF is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.

Research trials
Published clinical-trial protocols
Typical dose
No quantified dose captured for this tier.

No structured protocol details captured for this tier yet.

Clinician practice
Doctor & published-protocol guidance · n = 2
Typical dose
200 µg
200 µg
200 µg
Frequency
weekly
Timing
unspecified
Route
IM
Cycle
unspecified

Clinician protocols dose 200 µg weekly IM (2 sources).

2 sources
Anecdotal
Community-reported real-world use · n = 8
Typical dose
No quantified dose captured for this tier.
Frequency
unspecified
Timing
unspecified
Route
not specified
Cycle
unspecified

Community reports mention MGF use for muscle growth, recovery, and injury healing. Doses, frequencies, and routes are not consistently reported across these anecdotal accounts.

Peptide Deep Dive

Peptide Deep Dive is not projected for this peptide yet.

Peptide feedback

0 forum replies

Live community discussion for MGF, shown here in the site layout and continued on the TVR forum.

Add feedback

No peptide feedback yet

Start the peptide feedback thread on the TVR forum.